Coronary Stents Market to Showcase Robust Growth in the Upcoming Years | Major players: Coronary Stents Market include Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Te

The Global Coronary Stents Market was valued at USD 9.27 billion in 2021, growing at a CAGR of 7.51% during the forecast period from 2022 to 2027, to reach USD 14.28 billion by 2027.

The rise in demand for coronary stents is primarily attributed to the rising prevalence of cardiovascular disorders such as stroke, atherosclerosis, heart attack due to increasing geriatric population; growing number of PCI (Percutaneous Coronary Intervention) procedures; increase in demand for minimally invasive surgeries, technological advancement in the product line, among others.

Find a sample copy of the Coronary Stents Market report @ https://www.delveinsight.com/sample-request/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Coronary Stents Overview

Coronary stents are medical devices used to treat narrowed or blocked arteries in the heart. These devices are deployed during a procedure called coronary angioplasty or percutaneous coronary intervention (PCI) to restore blood flow to the heart muscle. Coronary stents provide structural support to keep the artery open and prevent it from collapsing again. Here are some key points about coronary stents:

Types of Coronary Stents:

Bare-Metal Stents (BMS): These stents are made of metal (usually stainless steel) and provide a scaffold to keep the artery open. They are effective in preventing immediate re-narrowing after angioplasty, but they may be associated with a higher risk of restenosis (re-narrowing over time).
Drug-Eluting Stents (DES): Drug-eluting stents are coated with medications (usually anti-proliferative drugs) that are slowly released to inhibit cell growth and reduce the risk of restenosis. DES has become more widely used due to their improved efficacy in preventing re-narrowing.

Bioresorbable Stents:

Bioresorbable stents are designed to gradually dissolve over time, leaving behind a healed artery. While their use has been explored, they are not as commonly used as bare-metal or drug-eluting stents, and research is ongoing to assess their long-term effectiveness and safety.

Stent Delivery Systems:

Stents are delivered to the blocked or narrowed artery using a catheter-based system. The stent is mounted on a balloon at the tip of the catheter. During the procedure, the balloon is inflated to compress the plaque and expand the stent, which is then left in place to support the artery.

Indications for Stent Placement:

Coronary stents are typically used to treat coronary artery disease (CAD), which involves the build-up of plaque (atherosclerosis) in the arteries that supply blood to the heart muscle. Stents are used to open narrowed or blocked arteries, improving blood flow and reducing symptoms such as chest pain (angina).

Risks and Complications:

While coronary stents are effective in treating coronary artery disease, there are potential risks and complications associated with the procedure. These may include bleeding, blood vessel damage, stent thrombosis (clot formation), and restenosis.
Antiplatelet Medications:

Patients who receive coronary stents are usually prescribed antiplatelet medications, such as aspirin and a P2Y12 inhibitor (e.g., clopidogrel), to prevent blood clot formation around the stent. This dual antiplatelet therapy is typically continued for a certain duration to reduce the risk of stent thrombosis.
Follow-up Care:

Patients who undergo coronary stent placement require regular follow-up care with their healthcare providers. Monitoring includes imaging studies (angiography) and adjustments to medications as needed.

Coronary stent placement has become a common and effective intervention for managing coronary artery disease. The choice between bare-metal and drug-eluting stents depends on various factors, including the patient's medical history, anatomy of the blocked artery, and the risk of restenosis. Advances in stent technology continue to improve outcomes and reduce complications associated with these interventions.

Read more about the operations & working of Coronary Stents @ https://www.delveinsight.com/report-store/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Coronary Stents Market Drivers

The major drivers driving the demand for Coronary Stents are the growing burden of the old age population susceptible to various cardiovascular disorders, shifting preferences towards minimally invasive surgeries, technological advancement in the product line, among others.

Coronary Stents Market Dynamics

According to WHO 2021 report, in 2019, CVD was the leading cause of death across the globe accounting for an estimated 17.9 million deaths which represent 32% of all the global deaths. Out of these CVD deaths, 85 % were due to stroke and heart attack. Moreover, according to a study published in NCBI 2020, Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study by Khan M. AB, et al., Ischemic heart disease (IHD) affected around 126 million individuals (1,655 per 100,000), which was approximately 1.72% of the world's population and around nine million deaths were caused by IHD globally. As per the same study, the global prevalence of IHD is rising and the current prevalence rate of 1,655 per 100,000 population is expected to exceed 1,845 by the year 2030. Thus, rising prevalence of IHD is contributing to the market growth of coronary stents as these stents are inserted into coronary arteries via a catheter to widen the artery and increase blood flow to ischaemic heart muscle.

In addition, the growing number of PCI (Percutaneous Coronary Intervention) procedures is also a driving factor for the coronary stent market. For instance, according to a study published in NCBI 2021, Anticoagulants Used in Cardiac Catheterization of Patients With Chronic Lymphocytic Leukemia: A Case Report and Overview by Mararenko A. et al., Percutaneous coronary intervention (PCI) is one of the most frequently performed minimally invasive procedures and also plays a key role in the long-term survival of patients with ischemic heart disease. According to the study, over 965,000 angioplasties are performed annually in the United States alone. Thus, rising PCI surgery numbers can boost the global coronary stents market.

Certain factors such as few product recalls, risk of restenosis, and high cost of the procedure may pose a minor hurdle for the growth of the coronary stents market.

Interested in knowing how the Coronary Stents Market will be growing by 2026? Click to get a snapshot: https://www.delveinsight.com/report-store/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Coronary Stents Market Insights

Among all the countries, North America is expected to dominate the overall Coronary Stents market during the forecast period. This domination is due to the improved healthcare infrastructure, favorable reimbursement scenario in the region.

Further, in the United States the rising prevalence of coronary heart diseases and other CVDs is projected to boost the coronary stent market in the region. For instance, as per the data of American Heart Association 2021, in the year 2018, Coronary Heart Disease (CHD) was the leading cause (42.1%) of deaths attributable to CVD in the US, followed by stroke (17.0%), high blood pressure (11.0%), Heart failure (9.6%), diseases of the arteries (2.9%), and other CVD (17.4%). Coronary artery diseases or coronary heart diseases are characterized by narrowing of arteries due deposition of cholesterol which require coronary stents to open the arteries for proper blood flow. Thereby, fuelling the coronary stents market.

In addition, presence of key manufacturers such as Medtronic, Boston Scientific Corporation, among others is also likely to boost the coronary stents market. Furthermore, recent product approval in the region will also contribute to the market growth. For instance, in 2019, German medical device company Biotronik received U.S. Food and Drug Administration (FDA) approval for Orsiro drug-eluting coronary stent (DES) system.

Europe and Asia-Pacific region has the future potential growth for the Global Coronary Stents. This is due to the rising burden of geriatric population in the European region countries and in Asian countries also. Rapid urbanization, increase in disposable income, improved government funding towards cardiovascular disorder management, and growing healthcare awareness are the factors that are likely to drive the market. In addition, low manufacturing cost of coronary stents, new product approval and launch in the region is also expected to pose a lucrative market growth. For instance, in 2019, Meril Life Sciences (India) launched Evermine50, an everolimus-eluting coronary stent system.

To know more about why North America is the leader in market growth for the Coronary Stents market, get a snapshot of the report: https://www.delveinsight.com/report-store/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Coronary Stents Companies

Some of the key market players operating in the Coronary Stents market includes Coronary Stents Market include Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., and others.

To understand key companies related to the Coronary Stents Market, get a snapshot of the Coronary Stents Regulatory and Patent Analysis, visit: https://www.delveinsight.com/report-store/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Table of Contents

1. Coronary Stents Market Report Introduction
2. Coronary Stents Market Executive Summary
3. Regulatory and Patent Analysis
4. Coronary Stents Market Key Factors Analysis
5. Coronary Stents Market Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Coronary Stents Market
7. Coronary Stents Market Layout
8. Coronary Stents Market Global Company Share Analysis - Key 3-5 Companies
9. Coronary Stents Market Company and Product Profiles
10. Project Approach
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight

Request the TOC of the Coronary Stents Market report here https://www.delveinsight.com/sample-request/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Contact Us:

Kritika Rehani
info@delveinsight.com
+91-9650213330
www.delveinsight.com

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.